trial · primary record
BL-M14D1
Small Cell Lung Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 115 |
| Primary completion | 2027-06 |
| Primary endpoint | Phase Ia: Dose limiting toxicity (DLT) |
| Registry ID | NCT06505824 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:59.612Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06505824
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bl-m14d1 · compound